an update on the phase i/ii ruby trial of reni-cel gene therapy in patients with severe scd
Published 1 month ago • 79 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
12:55
my honest rodan and fields skincare review
-
4:49
myelofibrosis - causes, symptoms, diagnosis, treatment, pathology
-
56:52
dr. christopher mason | the next 500 years | talks at google
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:53
the future of multiple myeloma treatment
-
5:07
daratumumab in the management of al amyloidosis
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
1:02
maintenance therapy following treatment for amyloidosis
-
5:18
upfront treatment in transplant candidates
-
1:37
mrd in myeloma
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
1:33
rnai therapeutics for attr amyloidosis
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
1:47
shared treatment decision-making
-
8:34
hct in mds: cell source and conditioning type